Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1998-2-3
pubmed:abstractText
The effects of granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin (IL)-3 and IL-6 on clonogenic growth of blast-cell progenitors from 19 immunologically defined CD10-positive B-lineage acute lymphoblastic leukemias (ALL) coexpressing (My+ALLs) or not (My-ALLs) myeloid antigens have been studied. Our results demonstrate that GM-CSF was able to support the clonogenic growth of blast cells from My+ALLs, being totally ineffective on My-All samples. Accordingly, both alpha and beta chains of GM-CSF receptor (R) were expressed by My+ALL blasts, as investigated by reverse-transcriptase polymerase chain reaction (RT-PCR). Colony cells from GM-CSF-stimulated My+ALL cultures displayed the same immunophenotype as primary leukemic cells at diagnosis (CD10+, CD19+, CD22+), and retained the expression of myeloid-associated antigens and of GM-CSF-R transcripts. Moreover, My+ALL blasts showed a preferential sensitivity to the growth-promoting activity of IL-3 and IL-6, as compared with My-ALL cells. In addition to rearrangements of the JH region of immunoglobulin genes, My+ALL cells showed aberrant rearrangements of gamma (three cases) and beta (two cases) T-cell receptor genes, as well as of bcr sequences (three cases). Our data, showing an unexpected cross-lineage response of My+ALLs to GM-CSF, and their preferential stimulation by IL-3 and IL-6, as compared with My-ALLs, further support the concept that My+ALLs represent a separate entity with unique biological features.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
1368-4736
pubmed:author
pubmed:issnType
Print
pubmed:volume
3
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
141-51
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:9426972-Adolescent, pubmed-meshheading:9426972-Adult, pubmed-meshheading:9426972-Aged, pubmed-meshheading:9426972-Antigens, CD, pubmed-meshheading:9426972-Burkitt Lymphoma, pubmed-meshheading:9426972-Cell Division, pubmed-meshheading:9426972-Child, Preschool, pubmed-meshheading:9426972-Clone Cells, pubmed-meshheading:9426972-Female, pubmed-meshheading:9426972-Gene Rearrangement, pubmed-meshheading:9426972-Granulocyte-Macrophage Colony-Stimulating Factor, pubmed-meshheading:9426972-Humans, pubmed-meshheading:9426972-Immunophenotyping, pubmed-meshheading:9426972-Interleukins, pubmed-meshheading:9426972-Male, pubmed-meshheading:9426972-Middle Aged, pubmed-meshheading:9426972-RNA, Messenger, pubmed-meshheading:9426972-Receptors, Granulocyte-Macrophage Colony-Stimulating Factor, pubmed-meshheading:9426972-Stem Cells
pubmed:year
1997
pubmed:articleTitle
Human granulocyte-macrophage colony-stimulating factor supports the clonogenic growth of B-lineage acute lymphoblastic leukemias expressing myeloid antigens.
pubmed:affiliation
Unità Operativa Leucemie e Trapianto di Midollo, IRCCS, Aviano, Italy. vgattei@ets.it
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't